Your browser doesn't support javascript.
loading
BCL6 promotes glioma and serves as a therapeutic target.
Xu, Liang; Chen, Ye; Dutra-Clarke, Marina; Mayakonda, Anand; Hazawa, Masaharu; Savinoff, Steve E; Doan, Ngan; Said, Jonathan W; Yong, William H; Watkins, Ashley; Yang, Henry; Ding, Ling-Wen; Jiang, Yan-Yi; Tyner, Jeffrey W; Ching, Jianhong; Kovalik, Jean-Paul; Madan, Vikas; Chan, Shing-Leng; Müschen, Markus; Breunig, Joshua J; Lin, De-Chen; Koeffler, H Phillip.
  • Xu L; Cancer Science Institute of Singapore, National University of Singapore, 117599, Singapore.
  • Chen Y; Cancer Science Institute of Singapore, National University of Singapore, 117599, Singapore.
  • Dutra-Clarke M; Board of Governors Regenerative Medicine Institute and Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
  • Mayakonda A; Cancer Science Institute of Singapore, National University of Singapore, 117599, Singapore.
  • Hazawa M; Cancer Science Institute of Singapore, National University of Singapore, 117599, Singapore.
  • Savinoff SE; Board of Governors Regenerative Medicine Institute and Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
  • Doan N; Department of Pathology and Laboratory Medicine, University of California, Los Angeles, and David Geffen School of Medicine, Los Angeles, CA 90095.
  • Said JW; Department of Pathology and Laboratory Medicine, University of California, Los Angeles, and David Geffen School of Medicine, Los Angeles, CA 90095.
  • Yong WH; Department of Pathology and Laboratory Medicine, University of California, Los Angeles, and David Geffen School of Medicine, Los Angeles, CA 90095.
  • Watkins A; Board of Governors Regenerative Medicine Institute and Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
  • Yang H; Cancer Science Institute of Singapore, National University of Singapore, 117599, Singapore.
  • Ding LW; Cancer Science Institute of Singapore, National University of Singapore, 117599, Singapore.
  • Jiang YY; Cancer Science Institute of Singapore, National University of Singapore, 117599, Singapore.
  • Tyner JW; Department of Cell & Developmental Biology, Oregon Health & Science University, Portland, OR 97239.
  • Ching J; Cardiovascular and Metabolic Disorders Program, Duke-NUS Graduate Medical School, 169857, Singapore.
  • Kovalik JP; Cardiovascular and Metabolic Disorders Program, Duke-NUS Graduate Medical School, 169857, Singapore.
  • Madan V; Cancer Science Institute of Singapore, National University of Singapore, 117599, Singapore.
  • Chan SL; Cancer Science Institute of Singapore, National University of Singapore, 117599, Singapore.
  • Müschen M; Department of Laboratory Medicine, University of California, San Francisco, CA 94143.
  • Breunig JJ; Board of Governors Regenerative Medicine Institute and Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048; dchlin11@gmail.com Joshua.Breunig@cshs.org.
  • Lin DC; Department of Medicine, University of California, Los Angeles School of Medicine, Los Angeles, CA 90095.
  • Koeffler HP; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
Proc Natl Acad Sci U S A ; 114(15): 3981-3986, 2017 04 11.
Article en En | MEDLINE | ID: mdl-28356518
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glioblastoma / Proteínas Proto-Oncogénicas c-bcl-6 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glioblastoma / Proteínas Proto-Oncogénicas c-bcl-6 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2017 Tipo del documento: Article